POS1197 IN DEPTH IDENTIFICATION OF RISK FACTORS FOR SEVERE COVID-19, REQUIRING HOSPITALIZATION, IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES: RESULTS OF A DUTCH NESTED CASE CONTROL STUDY (PRELIMINARY RESULTS)

نویسندگان

چکیده

Background: Several risk factors for severe COVID-19 have been identified 1 . An important question is whether in addition to these generic factors, patients with a potentially altered immune response, either by disease (inflammatory rheumatic diseases (IRDs)) or use of immunomodulatory agents (IA), carry higher lower COVID-19. In addition, several other potential suggested, such as vitamin D status and specific medication (NSAIDs, ACE-inhibitors) 2 Objectives: To identify COVID-19, requiring hospitalization, IRDs. Methods: Multicenter, unmatched nested case control study four rheumatology centers the Netherlands. Cases are IRD hospitalization between March st 2020 May 31 2020. Control not hospitalized within this period were included 1:4 ratio. Patient-, disease- treatment characteristics extracted (still ongoing) from electronic patient files, questionnaire was used collect additional data (e.g. on behavioral aspects). Potential analyzed using unconditional logistic regression, corrected confounders. Results: 77 cases 198 controls included. 26 died result 14 admitted ICU. Crude ORs female sex, age, BMI presence one more comorbidities 0.46 (95% CI 0.27-0.29), 1.1 (95%CI 1.0-1.1), 1.0 0.98-1.1) 3.0 1.7-5.2) respectively. Table displays OR, highlighted when OR <0.5/>2.0. Corrected significantly increased any IRD, but trend gout present. Use hydroxychloroquine (HCQ) shows protective effect, while csDMARDs than methotrexate HCQ leads Trends present rituximab (RTX), glucocorticoids ACE inhibitors, effect IL-6R blockers. Conclusion: The outcomes agreement research regarding related IRDs IA suggested RTX concern should be monitored closely. Strengths include low bias due effects only early pandemic included, completeness determinants interest ultimately, it provides answers relevant urgent question. References: [1]Williamson, Elizabeth J et al. “Factors associated COVID-19-related death OpenSAFELY.” Nature vol. 584,7821 (2020): 430-436. [2]Rizk, John G “Pharmaco-Immunomodulatory Therapy COVID-19.” Drugs 80,13 1267-1292. [3]Rentsch, Christopher T “Effect pre-exposure mortality: population-based cohort rheumatoid arthritis systemic lupus erythematosus OpenSAFELY platform.” Lancet Rheumatology 3,1 (2021): e19-e27. 1. factor ) RA* 1.38 (0.68 – 2.8) Spondylarthritis 0.60 (0.25-1.5) Gout 2.8 (0.80-9.8 Polymyalgia 0.54 (0.18-1.6) Systemic 1.6 (0.49-5.0) DMARDs (any 0.39 (0.17-0.88 Methotrexate 0.90 (0.46-1.7) 0.40 (0.16-0.98 Other 2.0 (0.99-4.1 bDMARDs (any) 0.96 (0.43-2.2) TNF-inhibitors (0.43-2.6) IL6R-blockers 0.43 (0.044 4.2 4.5 (0.25-79 tsDMARDs 0.89 (0.08-9.8) Glucocorticoids > 10 mg/day 2.5 (0.70-9.0 NSAIDs 0.82 (0.37-1.8) ACE-inhibitors 3.4 (1.6-7.1 Vitamin sufficient 0.77 (0.40-1.5) *incl. unspecified Disclosure Interests: Merel Opdam Grant/research support from: has received grants (to institution) Gilead, S Benoy: None declared, L.M. Verhoef: Sandra van Bijnen: Femke Lamers-Karnebeek: R.A.M. Traksel: Petra Vos: Alfons den Broeder consultancy honoraria, congress invitations Abbvie, Amgen, Cellgene, Roche, Biogen, Lilly, Novartis, Celltrion Sanofi, Gilead. Is coinventor patent (pending)., Jasper Broen Consultant of: fees Gilead Galapagos.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Risk Factors for Falls in Hospital In-Patients: A Prospective Nested Case Control Study

Background Patient falls are considered a challenge to the patient’s safety in hospitals, which, in addition to increasing the length of stay and costs, may also result in severe injuries or even the death of the patient. This study aims to investigate the associations between risk factors among fallers in comparison with the control group.   Methods A prospective nested...

متن کامل

Mortality Risk Factors in Patients with COVID-19 Infection: A Case-Control Study in Northeast of Iran

Background and Objectives: COVID-19 is a new disease and little information is available on its risk factors. The aim of this study was to determine the mortality risk factors in patients with COVID-19 in the northeast of Iran.     Materials and Methods: A case-control study was conducted. Patients of both sexes with a confirmed diagnosis of Covid-19 infection who died during the study were s...

متن کامل

the study of aaag repeat polymorphism in promoter of errg gene and its association with the risk of breast cancer in isfahan region

چکیده: سرطان پستان دومین عامل مرگ مرتبط با سرطان در خانم ها است. از آنجا که سرطان پستان یک تومور وابسته به هورمون است، می تواند توسط وضعیت هورمون های استروئیدی شامل استروژن و پروژسترون تنظیم شود. استروژن نقش مهمی در توسعه و پیشرفت سرطان پستان ایفا می کند و تاثیر خود را روی بیان ژن های هدف از طریق گیرنده های استروژن اعمال می کند. اما گروه دیگری از گیرنده های هسته ای به نام گیرنده های مرتبط به ا...

15 صفحه اول

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Annals of the Rheumatic Diseases

سال: 2021

ISSN: ['1468-2060', '0003-4967']

DOI: https://doi.org/10.1136/annrheumdis-2021-eular.1853